Ever Source Wealth Advisors, LLC Arvinas, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,103 shares of ARVN stock, worth $20,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,103
Previous 19
10968.42%
Holding current value
$20,441
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.2MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$91.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$60.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$35.7 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$32.1 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$20.9 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $517M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...